EWTX peer analysis
Edgewise Therapeutics (EWTX) against its competitors: price, today's move, 1-year return and market value side by side.
EWTX and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| CAPR Capricor | $8.95 | 4.07% | 43.73% | $500.00M |
| DYN Dyne Therapeutics | $18.07 | 4.09% | -13.88% | – |
| LRMR Larimar Therapeutics | $2.30 | -0.86% | -23.45% | $241.01M |
| PEPG PepGen | $2.50 | 7.68% | -45.81% | – |
| PTCT PTC Therapeutics | $65.39 | -0.43% | -8.07% | $5.49B |
| SLDB Solid Biosciences | $6.72 | 8.74% | 68.45% | $689.75M |
| SRPT Sarepta Therapeutics | $17.82 | 1.42% | -4.77% | $1.86B |
| STOK Stoke Therapeutics | $27.20 | 4.33% | 14.99% | $1.71B |
| TRDA Entrada Therapeutics | $4.89 | 7.47% | -32.42% | – |
| EWTX Edgewise Therapeutics | $45.28 | 16.48% | 147.84% | – |
- EWTX's peers: CAPR (Capricor), DYN (Dyne Therapeutics), LRMR (Larimar Therapeutics), PEPG (PepGen), PTCT (PTC Therapeutics), SLDB (Solid Biosciences), SRPT (Sarepta Therapeutics), STOK (Stoke Therapeutics).
Updated 2026-11-07 11:55 UTC